144 related articles for article (PubMed ID: 18706952)
1. The need for public education on HPV and cervical cancer prevention in Asia. Opinions of experts at the AOGIN conference.
Garland S; Park SN; Ngan HY; Frazer I; Tay EH; Chen CJ; Bhatla N; Pitts M; Shin HR; Konno R; Smith J; Pagliusi S; Park JS
Vaccine; 2008 Oct; 26(43):5435-40. PubMed ID: 18706952
[TBL] [Abstract][Full Text] [Related]
2. Recommendations for cervical cancer prevention in Asia Pacific.
Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
[TBL] [Abstract][Full Text] [Related]
3. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
Sankaranarayanan R; Bhatla N; Gravitt PE; Basu P; Esmy PO; Ashrafunnessa KS; Ariyaratne Y; Shah A; Nene BM
Vaccine; 2008 Aug; 26 Suppl 12():M43-52. PubMed ID: 18945413
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
[TBL] [Abstract][Full Text] [Related]
5. Recommendations for cervical cancer prevention and control in Ghana: public education and human papillomavirus vaccination.
Nartey Y; Hill P; Amo-Antwi K; Asmah R; Nyarko K; Yarney J; Damale N; Cox B
Ghana Med J; 2018 Jun; 52(2):94-102. PubMed ID: 30662082
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer burden and prevention strategies: Asia Oceania perspective.
Garland SM; Bhatla N; Ngan HY
Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1414-22. PubMed ID: 22956727
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
Tay SK; Ngan HY; Chu TY; Cheung AN; Tay EH
Vaccine; 2008 Aug; 26 Suppl 12():M60-70. PubMed ID: 18945415
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology and prevention of human papillomavirus and cervical cancer in China and Mongolia.
Shi JF; Qiao YL; Smith JS; Dondog B; Bao YP; Dai M; Clifford GM; Franceschi S
Vaccine; 2008 Aug; 26 Suppl 12():M53-9. PubMed ID: 18945414
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus-related content in state and tribal comprehensive cancer control plans.
Steele CB; Thomas CN; Richardson LC
J Womens Health (Larchmt); 2008; 17(1):5-10. PubMed ID: 18240976
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia.
Berkhof J; Bogaards JA; Demirel E; Diaz M; Sharma M; Kim JJ
Vaccine; 2013 Dec; 31 Suppl 7():H71-9. PubMed ID: 24332299
[TBL] [Abstract][Full Text] [Related]
11. Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia.
Touch S; Oh JK
BMC Cancer; 2018 Mar; 18(1):294. PubMed ID: 29544466
[TBL] [Abstract][Full Text] [Related]
12. Harnessing the power of prevention: human papillomavirus vaccines.
Mayeaux EJ
Curr Opin Obstet Gynecol; 2006 Feb; 18 Suppl 1():s15-21. PubMed ID: 16520680
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus infection and cervical cancer prevention in Japan and Korea.
Konno R; Shin HR; Kim YT; Song YS; Sasagawa T; Inoue M; Park JS
Vaccine; 2008 Aug; 26 Suppl 12():M30-42. PubMed ID: 18945412
[TBL] [Abstract][Full Text] [Related]
14. Quadrivalent human papillomavirus vaccine.
Barr E; Tamms G
Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
[TBL] [Abstract][Full Text] [Related]
15. Prevention of human papillomavirus (HPV) infection and cervical cancer in China: how does HPV vaccination bring about benefits to Chinese women?
Liu X; Feng A; Cui Y; Tobe RG
Biosci Trends; 2013 Aug; 7(4):159-67. PubMed ID: 24056165
[TBL] [Abstract][Full Text] [Related]
16. A questionnaire study on disparity of cervical cancer prevention programs in Asia-Oceania.
; Tse KY; Ushijima K; Tan AL; Intasorn P; Pariyar J; Chang CL; Domingo EJ; Konar H; Kumarasamy S; Tjokroprawiro BA; Wilailak S
J Obstet Gynaecol Res; 2023 Apr; 49(4):1230-1243. PubMed ID: 36726190
[TBL] [Abstract][Full Text] [Related]
17. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
Adams M; Jasani B; Fiander A
Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer prevention in the era of prophylactic vaccines: a preview for gynecologic oncologists.
; Collins Y; Einstein MH; Gostout BS; Herzog TJ; Massad LS; Rader JS; Wright J
Gynecol Oncol; 2006 Sep; 102(3):552-62. PubMed ID: 16979432
[TBL] [Abstract][Full Text] [Related]
19. Cervical cancer: screening and prevention.
Behtash N; Mehrdad N
Asian Pac J Cancer Prev; 2006; 7(4):683-6. PubMed ID: 17250453
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and prevention of cervical cancer in Indonesia, Malaysia, the Philippines, Thailand and Vietnam.
Domingo EJ; Noviani R; Noor MR; Ngelangel CA; Limpaphayom KK; Thuan TV; Louie KS; Quinn MA
Vaccine; 2008 Aug; 26 Suppl 12():M71-9. PubMed ID: 18945416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
